The challenge of the management of adolescents and young adults with soft tissue sarcomas

作者: Andrea Ferrari , Archie Bleyer , Shreyaskumar Patel , Stefano Chiaravalli , Patrizia Gasparini

DOI: 10.1002/PBC.27013

关键词:

摘要: Soft tissue sarcomas are relatively frequent in adolescents and young adults their clinical management may be complex, partly due to tumor associated factors, but also because different approaches have been adopted by pediatric adult medical oncologists dealing with the same disease. However, times changing last few years, has tended converge towards a common strategy. Continued increased international collaboration between sarcoma groups is of critical importance improve quality treatment as well research programs dedicated patients soft sarcomas.

参考文章(78)
S. Mathoulin-Pélissier, C. Chevreau, C. Bellera, E. Bauvin, M. Savès, P. Grosclaude, S. Albert, J. Goddard, S. Le Guellec, M. Delannes, B.N. Bui, J. Mendiboure, E. Stoeckle, J.M. Coindre, G. Kantor, M. Kind, A. Cowppli-Bony, S. Hoppe, A. Italiano, Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study Annals of Oncology. ,vol. 25, pp. 225- 231 ,(2014) , 10.1093/ANNONC/MDT407
James E. Butrynski, David R. D'Adamo, Jason L. Hornick, Paola Dal Cin, Cristina R. Antonescu, Suresh C. Jhanwar, Marc Ladanyi, Marzia Capelletti, Scott J. Rodig, Nikhil Ramaiya, Eunice L. Kwak, Jeffrey W. Clark, Keith D. Wilner, James G. Christensen, Pasi A. Jänne, Robert G. Maki, George D. Demetri, Geoffrey I. Shapiro, Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. The New England Journal of Medicine. ,vol. 363, pp. 1727- 1733 ,(2010) , 10.1056/NEJMOA1007056
Douglas S. Hawkins, James Robert Anderson, Leo Mascarenhas, Geoffrey Brian McCowage, David A. Rodeberg, Suzanne L. Wolden, David Parham, Lynn Million, Sarah S. Donaldson, Andrea Anita Hayes-Jordan, Kenneth L.B. Brown, Lisa A. Teot, Sheri L. Spunt, William H. Meyer, Vincristine, dactinomycin, cyclophosphamide (VAC) versus VAC/V plus irinotecan (VI) for intermediate-risk rhabdomyosarcoma (IRRMS): A report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. Journal of Clinical Oncology. ,vol. 32, pp. 10004- 10004 ,(2014) , 10.1200/JCO.2014.32.15_SUPPL.10004
David D'Adamo, Matthew Guo, Bartosz Chmielowski, Axel Le Cesne, George D Demetri, Shreyaskumar R Patel, Patrick Schöffski, Sant Chawla, Robert G Maki, Antoine Italiano, Hans Gelderblom, Edwin Choy, Giovanni Grignani, Veridiana Camargo, Sebastian Bauer, Sun Young Rha, Jean-Yves Blay, Peter Hohenberger, Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial The Lancet. ,vol. 387, pp. 1629- 1637 ,(2016) , 10.1016/S0140-6736(15)01283-0
Dario Callegaro, Rosalba Miceli, Sylvie Bonvalot, Peter Ferguson, Dirk C Strauss, Antonin Levy, Anthony Griffin, Andrew J Hayes, Silvia Stacchiotti, Cecile Le Pechoux, Myles J Smith, Marco Fiore, Angelo P Dei Tos, Henry G Smith, Luigi Mariani, Jay S Wunder, Raphael E Pollock, Paolo G Casali, Alessandro Gronchi, Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis Lancet Oncology. ,vol. 17, pp. 671- 680 ,(2016) , 10.1016/S1470-2045(16)00010-3
Sadaf Altaf, Felicity Enders, Elizabeth Lyden, Sarah S. Donaldson, David Rodeberg, Carola Arndt, Age-related toxicity in patients with rhabdomyosarcoma: a report from the children's oncology group. Journal of Pediatric Hematology Oncology. ,vol. 36, pp. 599- 604 ,(2014) , 10.1097/MPH.0000000000000192
Annalisa Trama, Laura Botta, Roberto Foschi, Andrea Ferrari, Charles Stiller, Emmanuel Desandes, Milena Maria Maule, Franco Merletti, Gemma Gatta, None, Survival of European adolescents and young adults diagnosed with cancer in 2000–07: population-based data from EUROCARE-5 Lancet Oncology. ,vol. 17, pp. 896- 906 ,(2016) , 10.1016/S1470-2045(16)00162-5
William D Tap, Robin L Jones, Brian A Van Tine, Bartosz Chmielowski, Anthony D Elias, Douglas Adkins, Mark Agulnik, Matthew M Cooney, Michael B Livingston, Gregory Pennock, Meera R Hameed, Gaurav D Shah, Amy Qin, Ashwin Shahir, Damien M Cronier, Robert Ilaria, Ilaria Conti, Jan Cosaert, Gary K Schwartz, Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial The Lancet. ,vol. 388, pp. 488- 497 ,(2016) , 10.1016/S0140-6736(16)30587-6
Andrea Ferrari, Shreyaskumar R. Patel, Jay Wunder, Karen H. Albritton, Soft Tissue Sarcoma Springer, Cham. pp. 383- 416 ,(2017) , 10.1007/978-3-319-33679-4_15